The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma

INTRODUCTION: A variety of biomarkers are considered for diagnosis (e.g., β2-microgobulin, albumin, or LDH) and prognosis [e.g., cytogenetic aberrations detected by fluorescence in situ hybridization (FISH)] of multiple myeloma (MM). More recently, clonal evolution has been established as key. Littl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandmann, Sarah, Karsch, Katharina, Bartel, Peter, Exeler, Rita, Brix, Tobias J., Mai, Elias K., Varghese, Julian, Lenz, Georg, Khandanpour, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343617/
https://www.ncbi.nlm.nih.gov/pubmed/35928862
http://dx.doi.org/10.3389/fonc.2022.919278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343617/
https://www.ncbi.nlm.nih.gov/pubmed/35928862
http://dx.doi.org/10.3389/fonc.2022.919278

Ejemplares similares